Aegis Wealth Management (Maryland)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-394
Closed -$228K – 124
2025
Q4
$228K Sell
394
-19
-5% -$10.7K 0.13% 114
2025
Q3
$200K Sell
413
-81
-16% -$37.7K 0.11% 122
2025
Q2
$246K Hold
494
– – 0.15% 103
2025
Q1
$246K Buy
+494
New +$268K 0.14% 108

Other funds holding TMO

Aegis Wealth Management (Maryland)'s TMO Position: Q1 2026 in Review

Aegis Wealth Management (Maryland) sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 394 shares — an estimated $228K sold.

Aegis Wealth Management (Maryland) first reported a position in TMO in Q1 2025 and held it in 4 quarters. The position peaked at $246K in Q2 2025. 2,612 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aegis Wealth Management (Maryland) reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Aegis Wealth Management (Maryland) sold 394 Thermo Fisher Scientific shares in Q1 2026, an estimated $228K.
  • Aegis Wealth Management (Maryland) first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 4 quarters.
  • Aegis Wealth Management (Maryland)'s Thermo Fisher Scientific position peaked at $246K in Q2 2025.
  • 2,612 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q1 2026, filed 23 Apr 2026.